136 related articles for article (PubMed ID: 36814925)
1. Single-cell RNA datasets and bulk RNA datasets analysis demonstrated
Tu J; Wang D; Zheng X; Liu B
Front Immunol; 2023; 14():911368. PubMed ID: 36814925
[TBL] [Abstract][Full Text] [Related]
2. ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing.
Qin Z; Luo K; Liu Y; Liao S; He J; He M; Xie T; Jiang X; Li B; Liu H; Huang Q; Tang H; Feng W; Zhan X
Int J Gen Med; 2022; 15():1033-1045. PubMed ID: 35140506
[TBL] [Abstract][Full Text] [Related]
3. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
Front Immunol; 2022; 13():992266. PubMed ID: 36405691
[TBL] [Abstract][Full Text] [Related]
4. Characterization of osteosarcoma subtypes mediated by macrophage-related genes and creation and validation of a risk score system to quantitatively assess the prognosis of osteosarcoma and reflect the tumor microenvironment.
Liu Z; Zhang L; Zhong Y
Ann Transl Med; 2022 Dec; 10(24):1318. PubMed ID: 36660647
[TBL] [Abstract][Full Text] [Related]
5. Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.
Yang J; Zhang J; Na S; Wang Z; Li H; Su Y; Ji L; Tang X; Yang J; Xu L
Front Immunol; 2022; 13():994034. PubMed ID: 36225939
[TBL] [Abstract][Full Text] [Related]
6. EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis.
Dai Z; Liu Z; Yang R; Cao W; Ji T
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830696
[TBL] [Abstract][Full Text] [Related]
7. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
8. Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma.
Yuan J; Yuan Z; Ye A; Wu T; Jia J; Guo J; Zhang J; Li T; Cheng X
Front Immunol; 2021; 12():758845. PubMed ID: 34691083
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma.
Huang H; Tan M; Zheng L; Yan G; Li K; Lu D; Cui X; He S; Lei D; Zhu B; Zhao J
Onco Targets Ther; 2021; 14():1737-1751. PubMed ID: 33707956
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
11. Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8
Xie T; Feng W; He M; Zhan X; Liao S; He J; Qin Z; Li F; Xu J; Liu Y; Wei Q
Exp Biol Med (Maywood); 2023 Jan; 248(2):130-145. PubMed ID: 36511103
[TBL] [Abstract][Full Text] [Related]
12. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
Liu R; Hu Y; Liu T; Wang Y
BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of single-cell and bulk RNA sequencing data reveals prognostic characteristics of lysosome-dependent cell death-related genes in osteosarcoma.
Wu Y; Yang J; Xu G; Chen X; Qu X
BMC Genomics; 2024 Apr; 25(1):379. PubMed ID: 38632516
[TBL] [Abstract][Full Text] [Related]
14. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
[TBL] [Abstract][Full Text] [Related]
15. MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration.
Du X; Zhang Q; Wang S; Chen X; Wang Y
J Clin Lab Anal; 2022 Feb; 36(2):e24214. PubMed ID: 34961985
[TBL] [Abstract][Full Text] [Related]
16. RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
Chen S; Zeng J; Huang L; Peng Y; Yan Z; Zhang A; Zhao X; Li J; Zhou Z; Wang S; Jing S; Hu M; Li Y; Wang D; Wang W; Yu H; Miao J; Li J; Deng Y; Li Y; Liu T; Xu D
J Transl Med; 2022 May; 20(1):228. PubMed ID: 35568866
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-related genes-based prognostic signature for osteosarcoma.
Yang F; Zhang Y
Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
[TBL] [Abstract][Full Text] [Related]
18. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
19. Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma.
Chen D; Wan B; Cheng Y; Luo Y; Bai X; Guo J; Li G; Jin T; Nie J; Liu W; Wang R
PeerJ; 2023; 11():e15814. PubMed ID: 37663298
[TBL] [Abstract][Full Text] [Related]
20. Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy.
Niu J; Yan T; Guo W; Wang W; Zhao Z; Ren T; Huang Y; Zhang H; Yu Y; Liang X
Front Oncol; 2020; 10():1628. PubMed ID: 32974202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
